These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 14512528
1. Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier. Xiang ZQ, Gao GP, Reyes-Sandoval A, Li Y, Wilson JM, Ertl HC. J Virol; 2003 Oct; 77(20):10780-9. PubMed ID: 14512528 [Abstract] [Full Text] [Related]
2. Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice. Xiang Z, Li Y, Gao G, Wilson JM, Ertl HC. J Immunol; 2003 Oct 15; 171(8):4287-93. PubMed ID: 14530353 [Abstract] [Full Text] [Related]
3. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. Xiang Z, Gao G, Reyes-Sandoval A, Cohen CJ, Li Y, Bergelson JM, Wilson JM, Ertl HC. J Virol; 2002 Mar 15; 76(6):2667-75. PubMed ID: 11861833 [Abstract] [Full Text] [Related]
10. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Xiang ZQ, Yang Y, Wilson JM, Ertl HC. Virology; 1996 May 01; 219(1):220-7. PubMed ID: 8623532 [Abstract] [Full Text] [Related]
17. Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration. Vos A, Neubert A, Pommerening E, Müller T, Döhner L, Neubert L, Hughes K. J Gen Virol; 2001 Sep 01; 82(Pt 9):2191-2197. PubMed ID: 11514729 [Abstract] [Full Text] [Related]